ELEDON PHARMACEUTICALS, INC.

Transcripts Eledon Pharmaceuticals, Inc.

Equities

ELDN

US28617K1016

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
3.02 ^USD	+7.86%		+30.74%	+67.78%

May. 07	Eledon Pharmaceuticals, Inc. Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection	CI
May. 06	Eledon Pharmaceuticals, Inc. announced that it expects to receive $49.99901 million in funding	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Eledon Pharmaceuticals, Inc. - Special Call	Nov. 02
Transcript : Eledon Pharmaceuticals, Inc., Q1 2023 Earnings Call, May 11, 2023	23-05-11
Transcript : Eledon Pharmaceuticals, Inc., Q4 2022 Earnings Call, Mar 30, 2023	23-03-30
Transcript : Eledon Pharmaceuticals, Inc., Q3 2022 Earnings Call, Nov 14, 2022	22-11-14
Transcript : Eledon Pharmaceuticals, Inc., Q2 2022 Earnings Call, Aug 11, 2022	22-08-11
Transcript : Eledon Pharmaceuticals, Inc. - Special Call	22-05-31
Transcript : Eledon Pharmaceuticals, Inc., Q1 2022 Earnings Call, May 12, 2022	22-05-12
Transcript : Eledon Pharmaceuticals, Inc. - Special Call	22-04-28
Transcript : Eledon Pharmaceuticals, Inc., Q4 2021 Earnings Call, Mar 24, 2022	22-03-24
Transcript : Eledon Pharmaceuticals, Inc., Q3 2021 Earnings Call, Nov 11, 2021	21-11-11
Transcript : Eledon Pharmaceuticals, Inc., Q2 2021 Earnings Call, Aug 12, 2021	21-08-12
Transcript : Eledon Pharmaceuticals, Inc., Q1 2021 Earnings Call, May 13, 2021	21-05-13
Transcript : Eledon Pharmaceuticals, Inc., Q4 2020 Earnings Call, Mar 30, 2021	21-03-30
Transcript : Novus Therapeutics, Inc., Q3 2020 Earnings Call, Nov 16, 2020	20-11-16
Transcript : Anelixis Therapeutics, LLC, Novus Therapeutics, Inc. - M&A Call	20-09-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW